Overview
Cancer susceptibility testing is a scientific tool used to assess a person's risk of developing certain types of cancer. It is based on the analysis of genetic variations associated with an individual’s predisposition to certain disease. This testing can help to identify those individuals who have an increased risk of developing cancer, allowing them to make informed decisions about their lifestyle and seek professional advice for early diagnosis and treatment. It is an important tool for cancer prevention and helps to identify individuals who may benefit from targeted interventions such as modifications in lifestyle, surveillance, and chemoprevention.
Research published in this journal
2 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Functional, Structural and Contextual Analysis of a Variant of Uncertain Clinical Significance in BRCA1: c.5434C->G (p. Pro1812Ala)
How this research is being cited
The 2 articles above have been cited 7 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Genes
-
2025 · Open Journal of Genetics
-
2023 · Cells
-
2023 · Cells
-
2023 · CPT Pharmacometrics & Systems Pharmacology
-
2023 · CPT: Pharmacometrics & Systems Pharmacology
-
2017 · Journal of Cancer Genetics and Biomarkers
A sample of recent works citing this journal's research on Cancer Susceptibility Testing, linking to each citing work.